Quantcast

Posts related to ‘CRXX’

BioHealth Business Daily (ABIO, GENZ, SOMX, CRXX, VVUS, INO)

Today was a crazy day for the markets, and as you'd expect there were many movers in the drug and biotech sectors.  Today's edition of the BioHealth Business Daily covers ...
Read Full Story »

BioHealth Business Daily (BMRN, CRXX, MELA, GENZ, SLXP, SCLN, SOMX, WCRX, DNDN, CTIC)

Today’s BioHealth Business Daily has many new names and less followed companies, but there are some of the larger movers to consider today as well.  We are seeing news-related moves ...
Read Full Story »

The Unusual Suspects (BRK-B, CH, ECH, NBG, CRXX, COST, TM, F, RDY, MIL, PALM, SIRI)

This coming week we have many key issues coming front and center in our list of "Unusual Suspects."  Some are ongoing issues with mergers and the waves of earnings reports ...
Read Full Story »

Next Week’s Top Must Watch Issues (AIG, BRK-B, CRXX, COST, MIL, TMO, MMM, SIRI, PAY, F, TM)

Earnings season has mostly wound down.  We have many key business events and key economic events scheduled for next week.  In asset sales and merger land, we will be paying ...
Read Full Story »

Biotech Implosion: CombinatoRx (CRXX)

CombinatoRx, Incorporated (NASDAQ: CRXX) is seeing its stock implode this morning.  The company released data from its Phase IIb study of Synavive (CRx-102) for knee osteoarthritis showing that its Synavive ...
Read Full Story »

Biotech Busine$$ Daily (CRXX, CORT, OMRI, SIRT)

CombinatoRx, Incorporated (NASDAQ: CRXX) up 8% to $3.45 on no recent developments. The 52-week range is $3.11 to $7.37. Yesterday, the company hit a 52-week low so perhaps it had ...
Read Full Story »

The 52-Week Low Club (TDC)(WLSN)(PACT)(ABTL)

Teradata Corp (TDC) Not any news. Slow sell-off all day. Down to $20.11 from 52-week high of $30.08.Wilsons The Leather Experts (WLSN) CEO leaving. Falls to $.14 from 52-week high ...
Read Full Story »

The Day In Biotech Stocks (January 28, 2008) (ACOR, BIIB, CELG, PHRM, CRXX, LIPD, MDVN, PCOP)

Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis.  This data showed that Fampridine, which is designed to treat multiple ...
Read Full Story »

Pre-Market Stock News (May 11, 2007)

(AAPL) Apple’s talks about the Beatles are reportedly close to being settled.(ALL) Allstate is going to stop selling homeowners insurance policies in California.(ALU) Alcatel-Lucent earnings came out, forecasts 10% revenue ...
Read Full Story »